PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes
Cancer Treatment Reviews · 2026-06 · 147 · 103159
DOI: 10.1016/j.ctrv.2026.103159 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Treatment Reviews, 2026-06. Verfasst von Daniele Marinelli und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University, Rome, Italy; Department of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institu…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Medicine, Sapienza University, Rome, Italy; Department of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
- Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 200, 00128 Roma, Italy.
- Department of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy; Clinical and Molecular Medicine, Sapienza - Università di Roma, Rome, Italy.
- Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, the United States of America.
- Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 200, 00128 Roma, Italy; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medi…
- Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, the United States of America; Department of Clinical Oncology, Institute of Science Tokyo, Tokyo 1138510, Japan.
Zitieren
APA
Marinelli, D., Citarella, F., Torchia, A., Pannu, S., Aijaz, A., Sisca, L., Russano, M., Fujiwara, Y., Takada, K., Nassar, A. H., Banna, G. L., Ricciuti, B., Brunetti, L., Santo, V., Passaro, A., Saw, S. P. L., Li, M. S. C., Addeo, A., Ferrara, R., …, & Cortellini, A. (2026). PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes. Cancer Treatment Reviews, 147, 103159. https://doi.org/10.1016/j.ctrv.2026.103159
Vancouver
Marinelli D, Citarella F, Torchia A, Pannu S, Aijaz A, Sisca L, et al. PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes. Cancer Treatment Reviews. 2026;147:103159. doi:10.1016/j.ctrv.2026.103159
BibTeX
@article{Marinelli2026,
author = {Marinelli, Daniele and Citarella, Fabrizio and Torchia, Andrea and Pannu, Sagal and Aijaz, Ayesha and Sisca, Luisana and Russano, Marco and Fujiwara, Yu and Takada, Kazuki and Nassar, Amin H and Banna, Giuseppe Luigi and Ricciuti, Biagio and Brunetti, Leonardo and Santo, Valentina and Passaro, Antonio and Saw, Stephanie P L and Li, Molly S C and Addeo, Alfredo and Ferrara, Roberto and Di Maio, Massimo and Mountzios, Giannis and Santini, Daniele and Maugeri-Saccà, Marcello and Vincenzi, Bruno and Acker, Fabian and Reckamp, Karen L and Cappuzzo, Federico and Naqash, Abdul Rafeh and Cortellini, Alessio},
title = {PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes},
journal = {Cancer Treatment Reviews},
year = {2026},
volume = {147},
pages = {103159},
doi = {10.1016/j.ctrv.2026.103159}
}
EUVIMED